Glossary
- Adverse Event
- Arm assignment
- Assessment
- Background therapy
- Blinding
- Clinical study
- Control
- Cross-over trial
- Dosing discontinuation
- Early patient withdrawal (premature withdrawal)
- Eligibility Criteria
- Enrolment
- Epoch
- European Medicines Agency (EMA)
- Food and Drug Administration (FDA)
- Health Authority
- Indication
- Informed consent
- Institutional Review Board (IRB)